Physician profile
Steven M Sullivan
NPI 1700889789
$41,696.21
in general payments reported to CMS, 2019-2025
5 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,409 · 2020: $8,813 · 2021: $71.68 · 2022: $12K · 2023: $16K · 2024: $2,118 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $16K · Food and Beverage: $1,527 · Travel and Lodging: $493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $16,171.52 |
| Food and Beverage | $1,526.76 |
| Travel and Lodging | $493.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $39,378.34 | 2019-2024 | Walterlorenz Surgical Assist Arm |
| Kls-Martin L.P. | $1,147.65 | 2019-2025 | |
| Stryker Corporation | $1,037.84 | 2022-2024 | Patient-Fitted Tmj Reconstructive Prosthesis System, Na, Vsp System, Vsp Cranial |
| Osteomed LLC | $71.68 | 2021 | |
| Depuy Synthes Sales INC. | $60.70 | 2022-2023 | Matrixorthognathic, Matrixcombo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.